Nephrology Dialysis Transplantation, Vol 13, Issue 2 356-360, Copyright © 1998 by Oxford University Press
T LEhnert, E Keller, K Gondolf, T Schaffner, H Pavenstadt and P Schollmeyer
Background. The study was designed to investigate the
influence of haemodialysis on the pharmacokinetics of the non-ionic
contrast medium iopentol and the outcome of radiocontrast nephropathy in
patients at risk undergoing angiography. Methods. We
prospectively studied 30 patients with reduced renal function (mean serum
creatinine concentration (±SEM), 2.4±0.16 mg/dl
(212±14 &mgr;mol/l)). Patients were randomly assigned to
receive either a haemodialysis procedure for 3 h, started as soon as
possible (63±6 min) after administration of contrast medium, or
a conservative treatment. Serum concentration of iopentol and creatinine
were followed for up to 14 days. Results. The
extracorporeal plasma clearance of contrast medium was 71±2.5
ml/min. The fraction of the dose eliminated was 32±3%. The rate
of radiocontrast nephropathy (defined as serum creatinine increase of
⩾0.5 mg/dl (44 &mgr;mol/l) within 48 h) after administration of
contrast medium was similar in both groups (53 and 40% in group 1
(haemodialysis) and group 2 (conservative treatment) respectively). The
course of absolute changes in serum creatinine over the whole observation
period was not different in both groups. Conclusions.
The data indicate that haemodialysis eliminates contrast medium
effectively, but it may not influence the incidence or outcome of contrast
induced nephropathy. Keywords: haemodialysis;
radiocontrast nephropathy; iopentol
ORIGINAL ARTICLES
Effect of haemodialysis after contrast medium administration in patients with renal insufficiency
Department of Medicine, Division of Nephrology, University of Freiburg/Germany, Hugstetter Str. 55, D-79106 Freiburg, Germany; Corresponding author
![]()
CiteULike
Connotea
Del.icio.us What's this?